Diabetes News and Research

Latest Diabetes News and Research

Unique project to address key healthcare reform issue to be launched

Groundbreaking ceremonies on December 15 will mark the launch of a unique project that exemplifies how new technologies are being used to address a key healthcare reform issue: the multi-billion dollar cost of repeatedly hospitalizing patients with chronic conditions such as diabetes, high blood pressure, heart failure, asthma and lung disease.

5 Dec 2009

Oxygen Biotherapeutics commences enrollment in clinical trial of Oxycyte emulsion for TBI

Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

5 Dec 2009

Patients new to chronic disease medication face risk of medication discontinuation, finds study

In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment—with rates of discontinuation ranging from 29.6% to 78.1%.

5 Dec 2009

Researchers discover two new metabolic pathways

Case Western Reserve University researchers, from the School of Medicine's Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abuse, known as 4-hydroxyacids, are metabolized.

5 Dec 2009

Club Red Clinic offers preventive care for women with cardiovascular risk factors

When the University of Virginia Health System's new Club Red Clinic was on the drawing board, its organizers envisioned creating an innovative, cost-effective model for healthcare delivery. In a bold move, they decided to meld two timely healthcare concepts - prevention and shared medical appointments (SMAs) - into a unique clinical offering that has garnered overwhelmingly positive feedback from patients.

5 Dec 2009

FDA approves Santarus’ NDA for immediate-release prescription tablet product

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.

5 Dec 2009

Free health clinic offers preventive primary care for uninsured residents of Kansas City

The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also for anyone who is uninsured and has not seen a doctor recently. All participants in the health clinic will receive preventive primary care.

5 Dec 2009

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old.

4 Dec 2009

Rituximab drug may reduce long-term complications of type 1 diabetes

New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with insulin-dependent (type 1) diabetes.

4 Dec 2009

Senate bill moves forward, amendment ensures coverage for women's preventive care

Los Angeles Times: "After days of delay, Senate Democrats pushed ahead Thursday with their drive to pass a healthcare bill by Christmas, approving the first amendment to their giant bill: a measure to expand women's access to preventive services such as mammograms."

4 Dec 2009

Health Policy Research Roundup

UCLA Center For Health Policy Research: Health Disparities Among California's Nearly Four Million Low-Income Nonelderly Adult Women - Using data from the 2007 California Health Interview Survey, the authors of this policy brief compare low-income women, ages 18-64, to others. The report finds the low-income women are four times more likely to report fair or poor health and are more likely to report a health condition that interferes with basic physical activities, such as walking or climbing stairs.

4 Dec 2009

Geisinger Health System's diabetic bundling program pays dividends

Diabetes is one of the nation's most prevalent chronic diseases, and Geisinger has created a "bundle" of best practice measures to improve the quality of diabetes care and outcomes.

4 Dec 2009

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur more often in people who said they had been diagnosed with epilepsy versus those without an epilepsy diagnosis, according to a survey of approximately 173,000 households across the U.S.

4 Dec 2009

FDA approves once-daily SEROQUEL XR Extended Release Tablets

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD).

4 Dec 2009

New Center for Digestive Care to care for all aspects of digestive disease

The Center for Digestive Care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has been established with a mission to provide high-quality patient care, research and education for all aspects of digestive disease.

4 Dec 2009

Type 2 diabetics with CAD experience greater antiplatelet activity with prasugrel compared to clopidogrel

Results from a new study showed patients with type 2 diabetes who also had coronary artery disease (CAD) experienced greater antiplatelet activity with the investigational antiplatelet drug prasugrel compared to Plavix(R) (clopidogrel). Patients who received a 60 mg loading dose and 10 mg maintenance dose of prasugrel achieved significantly greater platelet inhibition compared with a 600 mg loading dose and 150 mg maintenance dose of Plavix.

4 Dec 2009

Detroit Science Center launches "Diabetes: A Deeper Look" traveling exhibit

In the United States, a person is diagnosed with diabetes every 21 seconds. On December 5, 2009, the Detroit Science Center will debut its newest exhibit, Diabetes: A Deeper Look, to help answer questions that the public might have about diabetes, diabetes treatment and the role insulin plays in the body.

4 Dec 2009

New SPC3649 drug found effective in treating HCV infections

In a dramatic finding, a new drug for hepatitis C virus (HCV) infections that targets liver cells produced a substantial drop in blood levels of the virus in animals and continued to work up to several months after treatment, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.

4 Dec 2009

Viral Genetics to develop drug therapies for immune-related disorders and diseases

The University of Colorado and Viral Genetics Inc., recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cancer based on the work of M. Karen Newell, Ph.D., a professor of biology at the University of Colorado at Colorado Springs.

4 Dec 2009

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

While most Canadian adults living with diabetes get regular care, they are not always getting all of the clinically recommended tests they require to prevent health complications.

4 Dec 2009

Diabetes News and Research

Latest Diabetes News and Research

Unique project to address key healthcare reform issue to be launched

Oxygen Biotherapeutics commences enrollment in clinical trial of Oxycyte emulsion for TBI

Patients new to chronic disease medication face risk of medication discontinuation, finds study

Researchers discover two new metabolic pathways

Club Red Clinic offers preventive care for women with cardiovascular risk factors

FDA approves Santarus’ NDA for immediate-release prescription tablet product

Free health clinic offers preventive primary care for uninsured residents of Kansas City

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

Rituximab drug may reduce long-term complications of type 1 diabetes

Senate bill moves forward, amendment ensures coverage for women's preventive care

Health Policy Research Roundup

Geisinger Health System's diabetic bundling program pays dividends

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

FDA approves once-daily SEROQUEL XR Extended Release Tablets

New Center for Digestive Care to care for all aspects of digestive disease

Type 2 diabetics with CAD experience greater antiplatelet activity with prasugrel compared to clopidogrel

Detroit Science Center launches "Diabetes: A Deeper Look" traveling exhibit

New SPC3649 drug found effective in treating HCV infections

Viral Genetics to develop drug therapies for immune-related disorders and diseases

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Diabetes News and Research

Latest Diabetes News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in